ID

29463

Beschreibung

Evaluation of Sildenafil for the Treatment of Moderate Congestive Heart Failure; ODM derived from: https://clinicaltrials.gov/show/NCT00793338

Link

https://clinicaltrials.gov/show/NCT00793338

Stichworte

  1. 28.03.18 28.03.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

28. März 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Heart Failure NCT00793338

Eligibility Heart Failure NCT00793338

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
age greater than 18 years
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
diagnosis of chronic heart failure with an ejection fraction less than or equal to 45% per either an echocardiogram, nuclear cardiolyte stress test, or cardiac catheterization performed within the past 6 months.
Beschreibung

Chronic heart failure | Cardiac ejection fraction Echocardiography | Cardiac ejection fraction Nuclear Stress Test | Cardiac ejection fraction Cardiac Catheterization

Datentyp

boolean

Alias
UMLS CUI [1]
C0264716
UMLS CUI [2,1]
C0232174
UMLS CUI [2,2]
C0013516
UMLS CUI [3,1]
C0232174
UMLS CUI [3,2]
C2825165
UMLS CUI [4,1]
C0232174
UMLS CUI [4,2]
C0018795
new york heart association functional class iii
Beschreibung

New York Heart Association Classification

Datentyp

boolean

Alias
UMLS CUI [1]
C1275491
must be on optimal heart failure therapy according to aha/acc heart failure guidelines, including treatment with acei and beta-blocker therapy, or have documented rationale for variation, including intolerance, contraindication, patient preference, or personal physician's judgment
Beschreibung

Therapeutic procedure Optimal Heart failure | Angiotensin-Converting Enzyme Inhibitors | Adrenergic beta-1 Receptor Antagonists | Rationale Variation | Intolerance | Medical contraindication | Patient Preference

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C2698651
UMLS CUI [1,3]
C0018801
UMLS CUI [2]
C0003015
UMLS CUI [3]
C0304516
UMLS CUI [4,1]
C2699007
UMLS CUI [4,2]
C0205419
UMLS CUI [5]
C1744706
UMLS CUI [6]
C1301624
UMLS CUI [7]
C0376409
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
comorbid disease or behavioral or other limitations that: 1) interfere with performing exercise test, or 2) prevent completion of 12 week study
Beschreibung

Comorbidity Interferes with Exercise testing | Behavior problem Interferes with Exercise testing | Comorbidity Preventing Completion of clinical trial | Behavior problem Preventing Completion of clinical trial

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0015260
UMLS CUI [2,1]
C0233514
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C0015260
UMLS CUI [3,1]
C0009488
UMLS CUI [3,2]
C1292733
UMLS CUI [3,3]
C2732579
UMLS CUI [4,1]
C0233514
UMLS CUI [4,2]
C1292733
UMLS CUI [4,3]
C2732579
currently pregnant or intent to become pregnant in the next 12 weeks or currently breastfeeding.
Beschreibung

Pregnancy | Pregnancy, Planned

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0032992
major cardiovascular event or cardiovascular procedure within the prior 6 weeks
Beschreibung

Cardiovascular event Major | Cardiovascular procedures Major

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1320716
UMLS CUI [1,2]
C0205164
UMLS CUI [2,1]
C0189573
UMLS CUI [2,2]
C0205164
history of chronic obstructive pulmonary disease or reactive airway disease
Beschreibung

Chronic Obstructive Airway Disease | Reactive airway disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0024117
UMLS CUI [2]
C3714497
known hypersensitivity to sildenafil
Beschreibung

Hypersensitivity Sildenafil

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0529793
current use of medications known to be a potent inhibitor of cyp3a4 (e.g., ritonavir, ketoconazole, itraconazole)
Beschreibung

Cytochrome P450 3A4 Inhibitor | Ritonavir | Ketoconazole | Itraconazole

Datentyp

boolean

Alias
UMLS CUI [1]
C3830624
UMLS CUI [2]
C0292818
UMLS CUI [3]
C0022625
UMLS CUI [4]
C0064113
current or recent (within 6 months) use of organic nitrate medications (e.g. isosorbide dinitrate, sublingual nitroglycerin)
Beschreibung

Organic nitrates | Isosorbide Dinitrate | Nitroglycerin Sublingual Product

Datentyp

boolean

Alias
UMLS CUI [1]
C3654024
UMLS CUI [2]
C0022252
UMLS CUI [3]
C3466369
known diagnosis of pulmonary veno-occlusive disease or non-arteritic anterior ischemic optic neuropathy
Beschreibung

Pulmonary Veno-Occlusive Disease | Nonarteritic anterior ischemic optic neuropathy

Datentyp

boolean

Alias
UMLS CUI [1]
C0034091
UMLS CUI [2]
C1852242

Ähnliche Modelle

Eligibility Heart Failure NCT00793338

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age greater than 18 years
boolean
C0001779 (UMLS CUI [1])
Chronic heart failure | Cardiac ejection fraction Echocardiography | Cardiac ejection fraction Nuclear Stress Test | Cardiac ejection fraction Cardiac Catheterization
Item
diagnosis of chronic heart failure with an ejection fraction less than or equal to 45% per either an echocardiogram, nuclear cardiolyte stress test, or cardiac catheterization performed within the past 6 months.
boolean
C0264716 (UMLS CUI [1])
C0232174 (UMLS CUI [2,1])
C0013516 (UMLS CUI [2,2])
C0232174 (UMLS CUI [3,1])
C2825165 (UMLS CUI [3,2])
C0232174 (UMLS CUI [4,1])
C0018795 (UMLS CUI [4,2])
New York Heart Association Classification
Item
new york heart association functional class iii
boolean
C1275491 (UMLS CUI [1])
Therapeutic procedure Optimal Heart failure | Angiotensin-Converting Enzyme Inhibitors | Adrenergic beta-1 Receptor Antagonists | Rationale Variation | Intolerance | Medical contraindication | Patient Preference
Item
must be on optimal heart failure therapy according to aha/acc heart failure guidelines, including treatment with acei and beta-blocker therapy, or have documented rationale for variation, including intolerance, contraindication, patient preference, or personal physician's judgment
boolean
C0087111 (UMLS CUI [1,1])
C2698651 (UMLS CUI [1,2])
C0018801 (UMLS CUI [1,3])
C0003015 (UMLS CUI [2])
C0304516 (UMLS CUI [3])
C2699007 (UMLS CUI [4,1])
C0205419 (UMLS CUI [4,2])
C1744706 (UMLS CUI [5])
C1301624 (UMLS CUI [6])
C0376409 (UMLS CUI [7])
Item Group
C0680251 (UMLS CUI)
Comorbidity Interferes with Exercise testing | Behavior problem Interferes with Exercise testing | Comorbidity Preventing Completion of clinical trial | Behavior problem Preventing Completion of clinical trial
Item
comorbid disease or behavioral or other limitations that: 1) interfere with performing exercise test, or 2) prevent completion of 12 week study
boolean
C0009488 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0015260 (UMLS CUI [1,3])
C0233514 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0015260 (UMLS CUI [2,3])
C0009488 (UMLS CUI [3,1])
C1292733 (UMLS CUI [3,2])
C2732579 (UMLS CUI [3,3])
C0233514 (UMLS CUI [4,1])
C1292733 (UMLS CUI [4,2])
C2732579 (UMLS CUI [4,3])
Pregnancy | Pregnancy, Planned
Item
currently pregnant or intent to become pregnant in the next 12 weeks or currently breastfeeding.
boolean
C0032961 (UMLS CUI [1])
C0032992 (UMLS CUI [2])
Cardiovascular event Major | Cardiovascular procedures Major
Item
major cardiovascular event or cardiovascular procedure within the prior 6 weeks
boolean
C1320716 (UMLS CUI [1,1])
C0205164 (UMLS CUI [1,2])
C0189573 (UMLS CUI [2,1])
C0205164 (UMLS CUI [2,2])
Chronic Obstructive Airway Disease | Reactive airway disease
Item
history of chronic obstructive pulmonary disease or reactive airway disease
boolean
C0024117 (UMLS CUI [1])
C3714497 (UMLS CUI [2])
Hypersensitivity Sildenafil
Item
known hypersensitivity to sildenafil
boolean
C0020517 (UMLS CUI [1,1])
C0529793 (UMLS CUI [1,2])
Cytochrome P450 3A4 Inhibitor | Ritonavir | Ketoconazole | Itraconazole
Item
current use of medications known to be a potent inhibitor of cyp3a4 (e.g., ritonavir, ketoconazole, itraconazole)
boolean
C3830624 (UMLS CUI [1])
C0292818 (UMLS CUI [2])
C0022625 (UMLS CUI [3])
C0064113 (UMLS CUI [4])
Organic nitrates | Isosorbide Dinitrate | Nitroglycerin Sublingual Product
Item
current or recent (within 6 months) use of organic nitrate medications (e.g. isosorbide dinitrate, sublingual nitroglycerin)
boolean
C3654024 (UMLS CUI [1])
C0022252 (UMLS CUI [2])
C3466369 (UMLS CUI [3])
Pulmonary Veno-Occlusive Disease | Nonarteritic anterior ischemic optic neuropathy
Item
known diagnosis of pulmonary veno-occlusive disease or non-arteritic anterior ischemic optic neuropathy
boolean
C0034091 (UMLS CUI [1])
C1852242 (UMLS CUI [2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video